InvestorsHub Logo
Followers 76
Posts 10333
Boards Moderated 0
Alias Born 02/23/2010

Re: None

Wednesday, 04/01/2020 8:12:32 AM

Wednesday, April 01, 2020 8:12:32 AM

Post# of 403510
In a broader context, demonstration of Brilacidin’s direct antiviral activity against the SARS-CoV-2 virus supports the drug’s unique 3-in-1 therapeutic potential—antiviral, anti-inflammatory, antimicrobial—to treat COVID-19
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News